eCite Digital Repository
Agomelatine monotherapy for autism-A case report
Citation
Naguy, A and Pridmore, S and Jamali, MA and Hasan, AE and Alamiri, B, Agomelatine monotherapy for autism-A case report, Psychopharmacology Bulletin, 52, (4) pp. 100-103. ISSN 0048-5764 (2022) [Contribution to Refereed Journal]
Abstract
ASD is commonly associated with a host of challenging behaviours. Pharmacotherapy is indicated if psycho-social and educational interventions fail. Atypical antipsychotics have the strongest evidence-base so far, with both risperidone and aripiprazole are FDA-approved. Unfortunately, their use is fraught with metabolic and neuro-hormonal side effects. Here, authors report on a case of ASD/mild ID with behavioural dyscontrol that failed multiple psychotropic trials and ultimately responded favourably to agomelatine monotherapy. This was achieved with excellent tolerability. This might open new venues in such complicated cases.
Item Details
| Item Type: | Contribution to Refereed Journal |
|---|---|
| Research Division: | Biomedical and Clinical Sciences |
| Research Group: | Clinical sciences |
| Research Field: | Psychiatry (incl. psychotherapy) |
| Objective Division: | Health |
| Objective Group: | Clinical health |
| Objective Field: | Treatment of human diseases and conditions |
| UTAS Author: | Pridmore, S (Professor Saxby Pridmore) |
| ID Code: | 154222 |
| Year Published: | 2022 |
| Deposited By: | Medicine |
| Deposited On: | 2022-11-14 |
| Last Modified: | 2022-11-14 |
| Downloads: | 0 |
Repository Staff Only: item control page